Trial NCT00719849

View at ClinicalTrials.gov 
Org. Study IDs: 2012.00
Secondary IDs: CDR0000597623 FHCRC-2012.00 T32CA009515

Last trial update was posted on 2017-06-14

MeSH Interventions

Antilymphocyte Serum Cyclophosphamide Cyclosporine Cyclosporins Fludarabine Fludarabine phosphate Mycophenolic Acid

MeSH Conditions

Leukemia Lymphoma Multiple Myeloma Myelodysplastic Syndromes Myelodysplastic-Myeloproliferative Diseases Myeloproliferative Disorders Neoplasms, Plasma Cell Plasmacytoma Preleukemia Syndrome

Other Conditions

Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic/Myeloproliferative Diseases

Stopping Reasons

A new protocol was developed to replace this protocol in 2008, with removal of ATG and extension of MMF duration.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID